A new study published in Diabetes Technology and Therapeutics showed that one of the main causes of postprandial and ...

an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart. Sanofi-Aventis' Merilog version of the product has been cleared for the treatment of adult and ...

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

Insulin aspart was the second rapidly acting analogue introduced, approved for clinical use in Europe in 1999 and by the FDA in 2000 for patients with Type 1 or Type 2 diabetes. It is obtained by ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill cartridge Novolog Mix 70/30 pen fill cartridge (Novo Nordisk ...

What is the pen all about? It is a pre-filled insulin pen containing insulin aspart, a fast-acting insulin analog. It helps glucose get into cells for energy, lowering blood sugar levels. It should be ...

A wave of biosimilar approvals, aggressive pricing strategies, and a regulatory sea change are setting the stage for ...

When it comes to managing blood sugar levels effectively, timing is everything. Aspart insulin is a fast-acting medication that helps regulate glucose spikes after meals. However, administering aspart ...

Consistency is crucial when it comes to natural blood sugar management methods. Developing long-term habits that include regular exercise, balanced eating patterns, and appropriate use of supplements ...